Four in 10 prostate cancer cases in the UK are diagnosed late, a study suggests.

The report by charity Orchid found a "worrying trend" of late diagnosis with 37% of prostate cancer cases diagnosed at stages three and four.

The report found one in four cases of prostate cancer was diagnosed in A&E.

The African Development Bank (AfDB) has called for increased and more quality investments in Africa’s health sector to achieve universal health coverage and address some of the health challenges currently confronting the continent. According to NAN, AfDB made the call on Saturday on the occasion of World Health Day tagged “Universal Health Coverage: everyone, everywhere”, with the slogan “Health for All”.

The National Agency for Food and Drug Administration and Control (NAFDAC) says there is no plastic fish in circulation in Nigeria. NAFDAC Management said in a statement in Abuja that its finding followed “a thorough investigation and analysis of some unsuspected plastic fish samples’’ in its laboratory.

Welcome To The Future, these were the opening words of Dr. Raqif who appeared on The Doctors Show to talk about a highly advanced brain supplement that is sending shock-waves through the medical community.

Major pharmaceutical companies were up in arms after The Doctors referred to it as “Viagra for the Brain”. This ground-breaking pill is called +IQ Points and many experts believe it could be the most powerful brain enhancer in the world.

It first came into the spotlight about 3 years ago when the creators of the “Limitless” movie cited +IQ Points as their inspiration for the fictional drug NZT-48.

There is hope for lung cancer sufferers worldwide. A breakthrough research has found that the use of two existing drugs could successfully treat the disease. The study delves deep into the molecular survival kit of lung tumours. Many cancer deaths are driven by the KRAS oncogene. KRAS is an essential gene, but in its mutant form, it is an important step in the generation of many types of cancer.

At least 23 out of the 57 Health Management Organisations (HMOs) have been delisted from the National Health Insurance Scheme (NHIS) having failed validity test carried out.

According to the newly inaugurated governing council of the scheme, the HMOs were blocked from having access to the NHIS scheme after they failed to meet up to the minimum operational standard of the program.

NHIS deals with two major components: Health Maintenance Organisations, HMOs and Health Service Providers, HSPs.